STAT3 and prostate carcinoma: Wang et al. indicated that oncolytic newcastle disease virus provoked the expression of ICD markers in prostate cancer cells, while combined inhibition of other targets such as STAT3 can enhance anti‐tumor effects against prostate cancer.25